Reneo Pharmaceuticals, Inc. (RPHM) - Winst- en verliesrekening per kwartaal

Home
RPHM
Financiële Gegevens

18.2 (USD) • At close October 4, 2024

Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Omzet Numbers are in millions	0	-0.734	0	0	0	0.734	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Kosten van de omzet Numbers are in millions	0	0.072	0	0	0.016	0.044	0.043	0.163	0.161	0.128	0.119	0.022	0.019	0.017	0.013	0.01	0.01	0	0	0	0
Brutowinst Numbers are in millions	0	-0.662	0	-0.012	-0.016	0.69	-0.043	-0.163	-0.161	-0.128	-0.119	-0.022	-0.019	-0.017	-0.013	-0.01	-0.01	0	0	0	0
Brutowinstmarge Numbers are in millions	0	0.902	0	0	0	0.94	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Onderzoek- en ontwikkelingskosten Numbers are in millions	13.012	20.731	0.904	0.59	4.926	17.56	13.622	14.4	10.991	10.357	9.938	8.132	9.278	7.1	9.318	6.279	5.472	5.118	4.431	2.817	3.578
Algemene en administratieve kosten Numbers are in millions	3.988	7.207	3.76	5.774	4.622	7.402	7.266	6.639	5.132	4.205	3.902	4.299	3.737	3.524	3.434	2.949	1.742	1.133	0.668	0.882	0.924
Verkoop- en marketingkosten Numbers are in millions	0	-1.062	0	0	0	1.062	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Verkoop-, algemene en administratieve kosten Numbers are in millions	3.988	8.269	3.76	5.774	4.622	8.464	7.266	6.639	5.132	4.205	3.902	4.299	3.737	3.524	3.434	2.949	1.742	1.133	0.668	0.882	0.924
Overige kosten Numbers are in millions	0	-3.593	0	0	1.138	1.452	1.692	1.508	1.016	0.962	0.833	0.119	-0.021	0.017	0.017	0.012	0.002	-0.002	0.005	0.012	0.071
Bedrijfskosten Numbers are in millions	17	29	4.664	6.364	9.548	26.024	20.888	21.039	16.123	14.562	13.84	12.431	13.015	10.624	12.752	9.228	7.214	6.251	5.099	3.699	4.502
Bedrijfsresultaat Numbers are in millions	-17	-12.39	-4.664	-6.364	-9.564	-26.068	-20.888	-21.039	-16.123	-14.562	-13.84	-12.431	-13.015	-10.624	-12.752	-9.228	-7.214	-6.251	-5.099	-3.699	-4.502
Bedrijfsresultaat ratio Numbers are in millions	0	16.88	0	0	0	-35.515	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Totaal overige inkomsten en kosten netto Numbers are in millions	0	49.731	0.972	1.003	1.138	1.452	1.692	1.508	1.016	0.962	0.833	0.119	-0.021	0.017	0.017	0.012	0.002	-0.002	0.005	0.012	0.071
Inkomen voor belasting Numbers are in millions	0	37.341	-3.692	-5.361	-8.426	-23.554	-19.196	-19.531	-15.107	-13.6	-13.007	-12.312	-13.036	-10.607	-12.735	-9.216	-7.212	-6.253	-5.094	-3.687	-4.431
Inkomen voor belasting ratio Numbers are in millions	0	-50.873	0	0	0	-32.09	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Belastingkosten Numbers are in millions	0	-1.032	0	0	-0.027	1.059	-0.043	-0.08	-1.016	-0.962	-0.833	0	0.021	-0.017	-0.034	-0.012	-0.002	0.004	-0.01	-0.012	-0.071
Nettowinst Numbers are in millions	0	37.341	-3.692	-5.361	-8.426	-23.554	-19.196	-19.531	-14.091	-12.638	-12.174	-12.312	-13.057	-10.607	-12.735	-9.216	-7.212	-6.253	-5.094	-3.687	-4.431
Nettowinstmarge Numbers are in millions	0	-50.873	0	0	0	-32.09	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
WPA (Winst Per Aandeel) Numbers are in millions	-1.19	-14.17	-1.1	-0.16	-0.25	-0.7	-0.57	-0.65	-0.56	-0.52	-0.5	-0.5	-0.53	-0.43	-0.52	-0.43	-0.3	-0.26	-0.65	-0.47	-0.57
Verwaterde WPA Numbers are in millions	-1.19	-14.17	-1.1	-0.16	-0.25	-0.7	-0.57	-0.65	-0.56	-0.52	-0.5	-0.5	-0.53	-0.43	-0.52	-0.43	-0.3	-0.26	-0.65	-0.47	-0.57
EBITDA Numbers are in millions	-17	35.937	-4.664	-6.352	-9.548	-26.024	-20.845	-20.997	-16.082	-14.434	-13.818	-12.409	-12.996	-10.607	-12.739	-9.218	-7.204	-6.241	-5.09	-3.69	-4.493
EBITDA ratio Numbers are in millions	0	-48.961	0	0	0	-35.455	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Reneo Pharmaceuticals, Inc.

NASDAQ:RPHM Add to watchlist

NASDAQ:RPHM